GLPwatch
Trials (2101)
Page 13 of 36.
- Spartina® (Tirzepatide) Effectiveness and Safety Evaluation
- BetaFIT Study: Beta Cell Imaging After Faecal mIcrobiota Transplantation
- Can Fat-Burning Shots Boost Fertility? Comparing Weight-Loss Injections vs. Healthy Habits for Obese Men With Low Sperm Health
- Comparison of Exenatide vs. Biphasic Insulin Aspart 30 on Glucose Variability in Type 2 Diabetes
- Post Marketing Surveillance Study of Byetta ™ (Exenatide) Use Among Filipino Patients
- Evaluation of the Impact of Intensive Short-Term Drug Therapy in Patients With Type 2 Diabetes Mellitus
- A Study of Tirzepatide (LY3298176) in Chinese Participants With Type 2 Diabetes (SURPASS-CN-MONO)
- Effects of a GLP-1 Receptor Agonist on Functional Activation and Connectivity of the Brain
- Efficacy and Safety of Semaglutide Once-weekly Versus Placebo in Drug-naïve Subjects With Type 2 Diabetes
- Observational Study on Effectiveness and Safety of Liraglutide in Subjects With Type 2 Diabetes
- Provide Pre-approval Expanded Access of LY3437943
- Effects of Liraglutide on the Cognitive Function in Patients With Type 2 Diabetes Mellitus
- Effect of Liraglutide for Weight Management in Paediatric Subjects With Prader-Willi Syndrome
- Relationship Between Improvement in Insulin Secretion and Decrease in HbA1c in GLP-1 RA Therapy in T2DM Patients
- Evaluating the Effect of the STEP@STAH Semaglutide Protocol on the Physical Health Measures of Atypical Antipsychotic-Treated Patients
- The Effects of Tirzepatide in People With Overweight/Obesity and Coronary Artery Disease
- A Master Protocol Study of Orforglipron (LY3502970) in Participants With Hypertension and Obesity or Overweight (ATTAIN-Hypertension) GZL1
- A Study to Evaluate the Efficacy and Safety of MEDI0382 in the Treatment of Overweight and Obese Subjects With Type 2 Diabetes
- GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Basal Insulin
- Polycystic Ovary Syndrome and Liraglutide as Add-on Therapy on Metformin
- BALANCE-OBS: Bofanglutide (GZR18) Versus Semaglutide in Latin American Adults With Overweight or Obesity
- A Research Study Comparing Active Drug in the Blood in Healthy Participants Following Dosing of the Current and a New Formulation (C) Semaglutide Tablets
- A 12 Month Site Randomized Trial in Adults With Type 2 Diabetes Mellitus and History of Cardiovascular Disease
- Exenatide (Byetta ®) Regulation of Intestinal and Hepatic Lipoprotein Particle Production in Humans
- Tailoring Obesity Treatment Trial
- A Phase I Study of 8-week Continuous Treatment With Polyethylene Glycol Loxenatide in Patients With Type 2 Diabetes
- Effect of Semaglutide on Cannabis Use in Adults With Cannabis Use Disorder
- Differences in Endothelial Function Amongst Sitagliptin and Liraglutide Users
- A Study of HS-20094 in T2DM Participants
- The Microvascular Function of GLP-1 and Its Analogues
- Assessment of the Efficacy and Safety of Lixisenatide in Patients With Type 2 Diabetes Insufficiently Controlled With Basal Insulin +/- Metformin
- Residual Gastric Content After Holding of Glucagon-like Peptide-1 Receptor Agonists Before Elective Surgery
- Semaglutide for Post-Smoking Cessation Weight Management
- The Effect of Liraglutide on Dietary Lipid Induced Insulin Resistance in Humans
- A Study in People With Overweight or Obesity to Test How Well Different Doses of BI 1820237 Are Tolerated When Given Alone or in Combination With Either Semaglutide or BI 456906
- Clinical Evaluation of 68Ga-NOTA-MAL-Cys39-exendin-4 Positron Emission Tomography in the Detection of Insulinoma
- 3mg Liraglutide for Overweight or Obesity
- A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Saudi Arabia, as Part of Local Clinical Practice
- Response to Semaglutide in Non-diabetic Obese Patients With Varying Degrees of Insulin Resistance
- AI-Assisted Lifestyle Intervention Versus Tirzepatide for Obesity and Newly Diagnosed Type 2 Diabetes
- A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in The Netherlands, as Part of Local Clinical Practice
- GLP-1 Receptor Expression in CHI
- Saxenda® in Obese or Overweight Patients With Stable Bipolar Disorder (Investigator Initiated)
- A Research Study to Compare Different Versions of Injectable CagriSema and Placebo in People With Excess Body Weight
- A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
- Effect of Liraglutide on Microbiome in Obesity
- Researching an Effect of GLP-1 Agonist on Liver STeatosis (REALIST)
- FLuctuATion Reduction With inSULin and Glp-1 Added togetheR (FLAT-SUGAR)
- Semaglutide Improves Metabolic Abnormalities and Fertility in Obese Infertile Women With Polycystic Ovary Syndrome
- Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination (FRC) Versus GLP-1 Receptor Agonist in Patients With Type 2 Diabetes, With a FRC Extension Period
- Liraglutide Use in Prader-Willi Syndrome
- Tirzepatide Monotherapy in Patients With Wolfram Syndrome Type 1
- Tirzepatide's Effects on Epigenetic Aging and Metabolic Restoration in Virally Suppressed People With HIV
- Feasibility of Aggressive Albuminuria Reduction in Biopsy-Proven Diabetic Nephropathy - a Pilot Study
- A Study of Dulaglutide (LY2189265) in Children and Adolescents With Type 2 Diabetes
- Effects of Antidiabetic Medications on the Postprandial State in Prediabetes
- Semaglutide for Metabolic Intervention and Adipose Loss to Treat Atrial Fibrillation
- Double-blinded, 6 Months Study With Bydureon® or Placebo in Adolescents With Obesity to Explore Changes in BMI
- Semaglutide (SEMA) for Alcohol Use Disorder (AUD) After Metabolic and Bariatric Surgery (MBS)
- GLP-1R Actions on Muscle and the Skeleton